Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Vanoli, E.
Right arrow Articles by Adamson, P. B
Right arrow Search for Related Content
PubMed
Right arrow Articles by Vanoli, E.
Right arrow Articles by Adamson, P. B
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The European Society of Cardiology

Experimental models of heart failure

Emilio Vanolia,b,c,*, Sara Bacchinia, Stefania Panigadaa, Francesco Pentimallia and Philip B Adamsonb,c

a Department of Cardiology, IRCCS Policlinico S. Matteo and University of Pavia, Pavia, Italy
b Departments of Physiology, Oklahoma University Health Sciences Center, Oklahoma City, OK, USA
c Department of Medicine Cardiology, Oklahoma University Health Sciences Center, Oklahoma City, OK, USA

* Correspondence: Emilio Vanoli, MD, FESC, Department of Cardiology, IRCCS San Matteo and University of Pavia, Italy. Tel./fax: +39 382529531 (E-mail: evanoli{at}compuserve.com).

Abstract

BACKGROUND: Most successful and reproducible animal models of chronic heart failure (HF) include: increased peripheral resistance, rapid ventricular pacing, arteriovenous shunt, supravalvular stenosis, chronic heart block, repetitive transmyocardial direct current (DC) shock. The main limitation of all these approaches was the lack of stability of the left ventricular (LV) dysfunction.

METHODS: We have described a stable and reproducible animal model of LV dysfunction mediated by ischemic loss of contractive myocardium, which is suitable for chronically studying the complex pathophysiology of HF. This model incorporates conscious dogs with a chronic anterior myocardial infarction (MI). Once the MI is stabilized the progression of the ischemic disease is produced by injecting into the circumflex coronary artery 1–2 cc of latex microspheres to cause embolization of microcirculation. This procedure is repeated 3–5 times over several weeks and, at the end, it results in a spread ischemic damage and a significant loss of ventricular systolic function.

RESULTS: The healed MI results in a depression of heart rate variability and baroreflex sensitivity in a subgroup of dogs. In these dogs the depressed vagal control of the heart is associated with elevated arrhythmic risk. On the contrary in dogs with preserved cardiac reflexes the arrhythmic risk is low. In the high risk group a profound electrophysiological remodelling occurs with the MI and progresses once LV dysfunction is created while the low risk dogs tolerate the embolization procedure with a loss in LV function but without the changes in the cardiac electrical stability.

CONCLUSION: Experimental preparations based on a chronic MI and progression of the ischemic damage toward a chronic LV dysfunction has provided important information concerning autonomic and electrophysiologic alterations associated with sudden cardiac death.

Keywords Experimental; Ischemia; Heart failure


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.